Nationwide Swedish study strengthens evidence for a third booster COVID vaccine dose

By | November 17, 2021
A nationwide study from Sweden investigates the effectiveness of COVID-19 vaccination against the risk of symptomatic infection, hospitalization, and death up to 9 months post-vaccination. This study is published on the Preprints with The Lancet website while awaiting peer review.